drugset / Trial / NCT00334412
COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis
RandomizedParallel-groupOpen-labelTreatment
Summary
Combination therapy of caspofungin and amphotericin B could be a useful treatment option in invasive fungal disease, but before it can be routinely recommended; carefully controlled and well-designed randomized clinical trials are needed.
Timeline
- Start
- 2004-03
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amphotericin B | Unknown | — | Intravenous |
| Subject | Caspofungin | Other / unclassified | — | Intravenous |